Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Cell Mol Neurobiol
1997 Feb 01;171:35-50. doi: 10.1023/a:1026325020191.
Show Gene links
Show Anatomy links
Potency of agonists and competitive antagonists on adult- and fetal-type nicotinic acetylcholine receptors.
Yost CS
,
Winegar BD
.
???displayArticle.abstract???
1. The potency of agonists and competitive antagonists on the two expressed forms of the nicotinic acetylcholine receptor (adult or junctional subtype, epsilon-AChR; fetal or extrajunctional subtype, gamma-AChR) have not previously been compared systematically in homogeneous receptor preparations. 2. Each subtype of the receptor was expressed separately in Xenopus oocytes by cytoplasmic injection of combinations of RNA transcribed in vitro. The presence of each type of receptor was confirmed by single-channel recordings. Expressing oocytes were assayed using discontinuous, single-electrode voltage clamp by measuring peak currents in response to test compounds. 3. The extrajunctional subtype was more potently activated by the nicotinic agonist dimethylphenyl piperazinium iodide (DMPP) than was the junctional form. There was no statistically significant difference in potency between the two subtypes for other nicotinic agonists (nicotine, cytisine and succinylcholine). The rank order of potency for epsilon-AChR was succinylcholine > cytisine > DMPP > nicotine, and that for gamma-AChR was DMPP > cytisine > succinylcholine > nicotine. 4. Two agonists (cytisine and succinylcholine) displayed six- to eight-fold greater intrinsic activity in activating epsilon-AChR over gamma-AChR. There was no difference between the two forms of receptor in efficacy for nicotine. 5. The extrajunctional form was much more potently inhibited by the steroidal competitive antagonist pancuronium than was the junctional receptor. However, there was no significant difference in potency of inhibition by the curariform drug atracurium. 6. Contrary to previous reports, there is no consistent relation between the effect of agonists and antagonists and the subtype of receptor. These data suggest that the resistance or sensitivity to these agents seen in various clinical settings are related to other cellular factors.
Bouzat,
Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors.
1994, Pubmed
Bouzat,
Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors.
1994,
Pubmed
Changeux,
The acetylcholine receptor: functional architecture and regulation.
1990,
Pubmed
Dascal,
The use of Xenopus oocytes for the study of ion channels.
1987,
Pubmed
,
Xenbase
Fu,
Competitive antagonists bridge the alpha-gamma subunit interface of the acetylcholine receptor through quaternary ammonium-aromatic interactions.
1994,
Pubmed
Goldman,
Spatial and temporal expression of acetylcholine receptor RNAs in innervated and denervated rat soleus muscle.
1989,
Pubmed
Goldman,
Acetylcholine receptor alpha-, beta-, gamma-, and delta-subunit mRNA levels are regulated by muscle activity.
1988,
Pubmed
Gu,
Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells.
1990,
Pubmed
Gu,
Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle.
1988,
Pubmed
Gu,
Characterization of acetylcholine receptor subunits in developing and in denervated mammalian muscle.
1988,
Pubmed
Gundersen,
Messenger RNA from human brain induces drug- and voltage-operated channels in Xenopus oocytes.
,
Pubmed
,
Xenbase
Katz,
The statistical nature of the acetycholine potential and its molecular components.
1972,
Pubmed
Kopta,
Comparison of mammalian adult and fetal nicotinic acetylcholine receptors stably expressed in fibroblasts.
1994,
Pubmed
Lingle,
Activation of skeletal muscle nicotinic acetylcholine receptors.
1992,
Pubmed
Luetje,
Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors.
1991,
Pubmed
,
Xenbase
Martyn,
Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers.
1992,
Pubmed
Melton,
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.
1984,
Pubmed
Mishina,
Molecular distinction between fetal and adult forms of muscle acetylcholine receptor.
,
Pubmed
,
Xenbase
Moorthy,
Resistance to non-depolarizing muscle relaxants in paretic upper extremities of patients with residual hemiplegia.
1980,
Pubmed
Salpeter,
Acetylcholine receptors in extrajunctional regions of innervated muscle have a slow degradation rate.
1992,
Pubmed
Sine,
Molecular dissection of subunit interfaces in the acetylcholine receptor: identification of residues that determine curare selectivity.
1993,
Pubmed
Sine,
Gamma- and delta-subunits regulate the affinity and the cooperativity of ligand binding to the acetylcholine receptor.
1991,
Pubmed
Steinbach,
Antagonist and partial agonist actions of d-tubocurarine at mammalian muscle acetylcholine receptors.
1995,
Pubmed
Stroud,
Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels.
1990,
Pubmed
Theroux,
Dose response of succinylcholine at the adductor pollicis of children with cerebral palsy during propofol and nitrous oxide anesthesia.
1994,
Pubmed
Unwin,
Acetylcholine receptor channel imaged in the open state.
1995,
Pubmed
Unwin,
Nicotinic acetylcholine receptor at 9 A resolution.
1993,
Pubmed
Witzemann,
Developmental regulation of five subunit specific mRNAs encoding acetylcholine receptor subtypes in rat muscle.
1989,
Pubmed
Yost,
Inhibition of the nicotinic acetylcholine receptor by barbiturates and by procaine: do they act at different sites?
1993,
Pubmed
,
Xenbase
